- Home
- SVII vs LUNG Comparison
SVII vs LUNG Comparison
Compare SVII & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVII
- LUNG
- Stock Information
- Founded
- SVII 2021
- LUNG 1995
- Country
- SVII United States
- LUNG United States
- Employees
- SVII N/A
- LUNG N/A
- Industry
- SVII Blank Checks
- LUNG Industrial Specialties
- Sector
- SVII Finance
- LUNG Health Care
- Exchange
- SVII Nasdaq
- LUNG Nasdaq
- Market Cap
- SVII 248.9M
- LUNG 248.0M
- IPO Year
- SVII 2022
- LUNG 2020
- Fundamental
- Price
- SVII $11.33
- LUNG $6.79
- Analyst Decision
- SVII
- LUNG Strong Buy
- Analyst Count
- SVII 0
- LUNG 7
- Target Price
- SVII N/A
- LUNG $13.71
- AVG Volume (30 Days)
- SVII 17.4K
- LUNG 213.2K
- Earning Date
- SVII 01-01-0001
- LUNG 10-28-2024
- Dividend Yield
- SVII N/A
- LUNG N/A
- EPS Growth
- SVII 36.87
- LUNG N/A
- EPS
- SVII 0.37
- LUNG N/A
- Revenue
- SVII N/A
- LUNG $76,583,000.00
- Revenue This Year
- SVII N/A
- LUNG $22.73
- Revenue Next Year
- SVII N/A
- LUNG $19.02
- P/E Ratio
- SVII $30.61
- LUNG N/A
- Revenue Growth
- SVII N/A
- LUNG 26.26
- 52 Week Low
- SVII $10.72
- LUNG $5.46
- 52 Week High
- SVII $11.33
- LUNG $14.84
- Technical
- Relative Strength Index (RSI)
- SVII 77.35
- LUNG 36.63
- Support Level
- SVII $11.20
- LUNG $6.39
- Resistance Level
- SVII $11.23
- LUNG $7.47
- Average True Range (ATR)
- SVII 0.01
- LUNG 0.34
- MACD
- SVII 0.00
- LUNG -0.18
- Stochastic Oscillator
- SVII 100.00
- LUNG 9.75
About SVII Spring Valley Acquisition Corp. II
Spring Valley Acquisition Corp II is a blank check company.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.